Nations Financial Group Inc, Regeneron Pharmaceuticals, Inc. Transaction History

Nations Financial Group Inc,

$1.34 Billion
Q3 2024

A detailed history of Nations Financial Group Inc, transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nations Financial Group Inc, holds 1,082 shares of REGN stock, worth $814,778. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,082

Previous 1,045 3.54%

Holding current value

$814,778

Previous $1.1 Million 3.55%

% of portfolio

0.09%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$1024.09 - $1201.76 $37,891 - $44,465	37 Added 3.54%	1,082 $1.14 Million
Q2 2024 Jul 29, 2024	SELL	$883.2 - $1071.19 $18,547 - $22,494	-21 Reduced 1.97%	1,045 $1.1 Million
Q1 2024 Apr 23, 2024	BUY	$902.69 - $993.35 $121,863 - $134,102	135 Added 14.5%	1,066 $1.03 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $4,651 - $5,290	6 Added 0.65%	931 $817,000
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $9,001 - $10,976	13 Added 1.43%	925 $761,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $1,400 - $1,660	-2 Reduced 0.22%	912 $655,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $29,261 - $35,559	43 Added 4.94%	914 $751,000
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $14,823 - $16,094	-21 Reduced 2.35%	871 $628,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $36,734 - $46,356	-64 Reduced 6.69%	892 $614,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $548 - $738	1 Added 0.1%	956 $565,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $41,658 - $48,890	70 Added 7.91%	955 $667,000
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $13,587 - $16,774	25 Added 2.91%	885 $559,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $14,924 - $17,704	-26 Reduced 2.93%	860 $521,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $15,129 - $17,873	32 Added 3.75%	886 $495,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $76,837 - $94,290	-172 Reduced 16.76%	854 $404,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $5,739 - $7,295	-12 Reduced 1.16%	1,026 $496,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $105,681 - $127,692	194 Added 22.99%	1,038 $581,000
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $64,131 - $83,709	130 Added 18.21%	844 $526,000
Q1 2020 May 08, 2020	BUY	$336.18 - $494.43 $240,032 - $353,023	714 New	714 $349,000

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

News

Stay updated on Nations Financial Group Inc, with notifications on news.

Account

Nations Financial Group Inc, Regeneron Pharmaceuticals, Inc. Transaction History